Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Smallanthus sonchifolius
Feuille yacon utilisée en jamu indonésien et traditionnellement en Amérique du Sud comme régulateur naturel de la glycémie.
Daun Insulin (Smallanthus sonchifolius), commonly known as yacon leaf, is a medicinal herb used in Indonesian Jamu and South American traditional medicine for blood sugar regulation. Its primary active compounds include fructooligosaccharides (FOS), chlorogenic acid, and sesquiterpene lactones, which contribute to its hypoglycemic, prebiotic, and hepatoprotective effects. Clinical evidence is limited to pilot studies and small trials, supporting its use as an adjunct in glycemic control.
Yacon leaf exerts hypoglycemic effects through multiple mechanisms. Fructooligosaccharides (FOS) act as prebiotics, promoting beneficial gut bacteria and increasing short-chain fatty acid production, which improves insulin sensitivity and reduces hepatic gluconeogenesis. Chlorogenic acid inhibits glucose-6-phosphatase and activates AMPK, enhancing peripheral glucose uptake. Sesquiterpene lactones inhibit α-glucosidase and α-amylase, reducing postprandial glucose absorption. Additionally, the herb exhibits antioxidant and anti-inflammatory properties that protect pancreatic beta-cells and improve liver function.
Feuille yacon utilisée en jamu indonésien et traditionnellement en Amérique du Sud comme régulateur naturel de la glycémie.
Daun Insulin (Smallanthus sonchifolius), commonly known as yacon leaf, is a medicinal herb used in Indonesian Jamu and South American traditional medicine for blood sugar regulation. Its primary active compounds include fructooligosaccharides (FOS), chlorogenic acid, and sesquiterpene lactones, which contribute to its hypoglycemic, prebiotic, and hepatoprotective effects. Clinical evidence is limited to pilot studies and small trials, supporting its use as an adjunct in glycemic control.
Yacon leaf exerts hypoglycemic effects through multiple mechanisms. Fructooligosaccharides (FOS) act as prebiotics, promoting beneficial gut bacteria and increasing short-chain fatty acid production, which improves insulin sensitivity and reduces hepatic gluconeogenesis. Chlorogenic acid inhibits glucose-6-phosphatase and activates AMPK, enhancing peripheral glucose uptake. Sesquiterpene lactones inhibit α-glucosidase and α-amylase, reducing postprandial glucose absorption. Additionally, the herb exhibits antioxidant and anti-inflammatory properties that protect pancreatic beta-cells and improve liver function.